SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-044016
Filing Date
2006-03-02
Accepted
2006-03-02 17:09:20
Documents
11
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 VIROPHARMA INCORPORATED - FORM 10-K d10k.htm 10-K 1235011
2 FORM OF CHANGE OF CONTROL AGREEMENT dex1013.htm EX-10.13 45155
3 AMENDMENT TO MANUFACTURING AGREEMENT dex1027.htm EX-10.27 24004
4 MASTER AGREEMENT dex1041.htm EX-10.41 200352
5 PROJECT AGREEMENT NO.1 dex1042.htm EX-10.42 106880
6 SCHEDULE OF RATIO OF EARNINGS TO FIXED CHARGES dex121.htm EX-12.1 17775
7 LIST OF SUBSIDIARIES dex21.htm EX-21 1752
8 CONSENT OF KPMG LLP dex23.htm EX-23 2533
9 SECTION 302 CERTIFICATION OF CEO dex311.htm EX-31.1 9397
10 SECTION 302 CERTIFICATION OF CFO dex312.htm EX-31.2 9272
11 SECTION 906 CERTIFICATIONS OF CEO AND CFO dex321.htm EX-32.1 3895
  Complete submission text file 0001193125-06-044016.txt   1657397
Mailing Address 397 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 397 EAGLEVIEW BLVD EXTON PA 19341 6104587300
VIROPHARMA INC (Filer) CIK: 0000946840 (see all company filings)

IRS No.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21699 | Film No.: 06660754
SIC: 2834 Pharmaceutical Preparations